Sanofi acquires Kadmon for $1.9bn

The French pharmaceutical company Sanofi announced it had reached a deal to buy US biopharmaceutical company Kadmon for 1.9 billion dollars. The deal comes only a month after the French firm purchased of another US biotech, Translate Bio, for $3.2 billion, Reuters reported. Sanofi elaborated it had offered $9.50 per share in cash for Kadmon, representing a total equity value of approximately $1.9 billion and that both companies' boards unanimously approved the transaction.

Sanofi's price tag represents a 79% premium on Kadmon's share price. "The acquisition supports Sanofi's strategy to continue to grow its general medicines core assets and will immediately add Rezurock (belumosudil) to its transplant portfolio," the two companies said in a joint statement. Rezurock, a treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease, was approved in July by the US Federal Drug Administration (FDA).

"Kadmon's pipeline includes drug candidates for immune and fibrotic diseases as well as immuno-oncology therapies", the companies said. Sanofi is under pressure to revive its medicine pipeline and is also eager to overcome setbacks in the Covid-19 vaccine race.

Similar articles

  • Google, Apple face pressure over Russian elections

    Google, Apple face pressure over Russian elections

    The US tech giants Google and Apple faced intense pressure over their actions which favored the ruling Russian party in the course of country’s parliamentary elections. Google and Apple removed an anti-government tactical voting app from their stores on the first day of the parliamentary election, Reuters elaborated.

    37
  • Skoda to halt Czech plants for a week due to chip shortage

    Skoda to halt Czech plants for a week due to chip shortage

    Czech carmaker Skoda Auto, part of the Volkswagen group, will halt production at two domestic plants for a week at the end of September due to chip shortages, the company said. This is yet the latest development of the global and unprecedented shortage in semiconductor microchips. Skoda has thousands of cars unfinished as it waits for chips.

    43
  • Apple's new iPhone: familiar design, faster chip

    Apple's new iPhone: familiar design, faster chip

    Apple is giving its iPhones a faster processor, with four new phones from Mini to Pro Max all set to head into the key Christman sales season with smoother performance in a very familiar design. The four iPhone 13 models, unveiled on Tuesday, maintain the sharp edges of their predecessors, while adding a number of incrementally better hardware improvements, news wires reported.

    47